These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Early diagnosis of gynecological cancer]. Puig-Tintoré LM, Jou Collell P. Med Clin (Barc); 1983 Jun 25; 81(3):131-5. PubMed ID: 6888070 [No Abstract] [Full Text] [Related]
5. [Reliability of pre-biopsy examination methods in the prevention of cancer of the uterine cervix]. Halko I. Bratisl Lek Listy; 1988 Jan 25; 89(1):27-30. PubMed ID: 3359338 [No Abstract] [Full Text] [Related]
9. The management of dysplasia, carcinoma in situ and microcarcinoma of the cervix. Brudenell M, Cox BS, Taylor CW. J Obstet Gynaecol Br Commonw; 1973 Aug 25; 80(8):673-9. PubMed ID: 4725942 [No Abstract] [Full Text] [Related]
10. Colposcopy and the conservative management of cervical dysplasia and carcinoma in situ. Chanen W, Hollyock VE. Obstet Gynecol; 1974 Apr 25; 43(4):527-34. PubMed ID: 4817004 [No Abstract] [Full Text] [Related]
12. [Diagnosis and clinical significance of dysplastic and neoplastic lesions of the cervix uteri. Treatment of the initial forms]. di Re R, Attili A. Minerva Ginecol; 1975 May 25; 27(5):365-71. PubMed ID: 1134684 [No Abstract] [Full Text] [Related]
19. [Value and critical significance of differential cytology in precancerous and early stages of cervix carcinoma]. Breinl H, Dehnhard F. Arch Gynakol; 1975 Nov 18; 219(1-4):61-3. PubMed ID: 1243510 [No Abstract] [Full Text] [Related]
20. The occurrence of isolated dysplastic and carcinoma in situ type cells in cervical smears from patients with dysplasia and carcinoma in situ: significance to prescreening using image processing techniques. Feldman M, Poulsen R, Shepherd L, Marshall KG. Acta Cytol; 1973 Nov 18; 17(5):395-400. PubMed ID: 4517951 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]